Breaking News Instant updates and real-time market news.

CODYY

Saint-Gobain

$0.00 /

+ (+0.00%)

12:10
09/07/20
09/07
12:10
09/07/20
12:10

Saint-Gobain upgraded to Buy from Hold at Societe Generale

Societe Generale analyst Xavier Marchand upgraded Saint-Gobain to Buy from Hold with a price target of EUR 41, up from EUR 35. The analyst expects "resilient" volumes and continued benefits from cost savings. Saint-Gobain is an attractive way to invest in the "Green deal," Marchand tells investors in a research note.

CODYY Saint-Gobain
$0.00 /

+ (+0.00%)

08/03/20 Morgan Stanley
Saint-Gobain price target raised to EUR 34 from EUR 33 at Morgan Stanley
07/06/20 JPMorgan
Saint-Gobain price target raised to EUR 37 from EUR 35 at JPMorgan
06/22/20 Societe Generale
Saint-Gobain downgraded to Hold from Buy at Societe Generale
06/08/20 UBS
Saint-Gobain price target raised to EUR 31 from EUR 28.50 at UBS

TODAY'S FREE FLY STORIES

General news
Fedspeak will be of interest in the week ahead with Chair Powell headlining » 13:20
11/27/20
11/27
13:20
11/27/20
13:20

Fedspeak will be of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

On The Fly
Fly Intel: Wall Street's top stories for Friday » 13:17
11/27/20
11/27
13:17
11/27/20
13:17
AZN

AstraZeneca

$52.59 /

-0.01 (-0.02%)

, MRNA

Moderna

$126.88 /

+17.7 (+16.21%)

, NVAX

Novavax

$125.68 /

+23.16 (+22.59%)

, SAGE

Sage Therapeutics

$75.59 /

-7.02 (-8.50%)

, BIIB

Biogen

$243.90 /

+1.85 (+0.76%)

, RYTM

Rhythm Pharmaceuticals

$29.27 /

+5.16 (+21.40%)

, MARA

Marathon Patent Group

$4.29 /

-0.805 (-15.80%)

, RIOT

Riot Blockchain

$6.25 /

-0.825 (-11.66%)

Stock futures saw modest…

ShowHide Related Items >><<
AZN AstraZeneca
$52.59 /

-0.01 (-0.02%)

MRNA Moderna
$126.88 /

+17.7 (+16.21%)

NVAX Novavax
$125.68 /

+23.16 (+22.59%)

SAGE Sage Therapeutics
$75.59 /

-7.02 (-8.50%)

BIIB Biogen
$243.90 /

+1.85 (+0.76%)

RYTM Rhythm Pharmaceuticals
$29.27 /

+5.16 (+21.40%)

MARA Marathon Patent Group
$4.29 /

-0.805 (-15.80%)

RIOT Riot Blockchain
$6.25 /

-0.825 (-11.66%)

AZN AstraZeneca
$52.59 /

-0.01 (-0.02%)

07:39 Today Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
06:25 Today Citi
Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff
11/24/20 Piper Sandler
Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler
11/23/20 Morgan Stanley
AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley
MRNA Moderna
$126.88 /

+17.7 (+16.21%)

07:39 Today Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/25/20 Goldman Sachs
Moderna price target raised to $139 from $107 at Goldman Sachs
11/23/20
Fly Intel: Top five analyst initiations
11/23/20 Wells Fargo
Moderna initiated with an Equal Weight at Wells Fargo
NVAX Novavax
$125.68 /

+23.16 (+22.59%)

11/17/20 H.C. Wainwright
Novavax price target lowered to $207 from $290 at H.C. Wainwright
10/30/20 Cantor Fitzgerald
Cantor says Novavax vaccine could be 'best-in-class,' but not 'first-in-class'
10/22/20 B. Riley Securities
Novavax price target lowered to $223 from $257 at B. Riley Securities
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
SAGE Sage Therapeutics
$75.59 /

-7.02 (-8.50%)

10:16 Today Stifel
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage
11/19/20 Oppenheimer
Sage Therapeutics price target raised to $94 from $65 at Oppenheimer
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Morgan Stanley
Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations
BIIB Biogen
$243.90 /

+1.85 (+0.76%)

10:16 Today Stifel
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage
11/10/20 Truist
Truist raises Biogen price target to $443, views aducanumab approval as 'likely'
11/10/20 DZ Bank
Biogen upgraded to Buy from Hold at DZ Bank
11/09/20 BMO Capital
Biogen price target lowered to $253 from $343 at BMO Capital
RYTM Rhythm Pharmaceuticals
$29.27 /

+5.16 (+21.40%)

11:25 Today Stifel
Rhythm's Imcivree label 'reads bullish' for possible basket trial, says Stifel
10/26/20 Stifel
Rhythm Pharmaceuticals price target raised to $36 from $31 at Stifel
01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
MARA Marathon Patent Group
$4.29 /

-0.805 (-15.80%)

11/23/20 H.C. Wainwright
Marathon Patent Group initiated with a Buy at H.C. Wainwright
RIOT Riot Blockchain
$6.25 /

-0.825 (-11.66%)

11/23/20 H.C. Wainwright
Riot Blockchain price target raised to $7.50 from $3.50 at H.C. Wainwright
AZN AstraZeneca
$52.59 /

-0.01 (-0.02%)

MRNA Moderna
$126.88 /

+17.7 (+16.21%)

NVAX Novavax
$125.68 /

+23.16 (+22.59%)

SAGE Sage Therapeutics
$75.59 /

-7.02 (-8.50%)

BIIB Biogen
$243.90 /

+1.85 (+0.76%)

RYTM Rhythm Pharmaceuticals
$29.27 /

+5.16 (+21.40%)

MARA Marathon Patent Group
$4.29 /

-0.805 (-15.80%)

  • 24
    Jul
  • 19
    May
  • 12
    Feb
AZN AstraZeneca
$52.59 /

-0.01 (-0.02%)

MRNA Moderna
$126.88 /

+17.7 (+16.21%)

NVAX Novavax
$125.68 /

+23.16 (+22.59%)

BIIB Biogen
$243.90 /

+1.85 (+0.76%)

AZN AstraZeneca
$52.59 /

-0.01 (-0.02%)

MRNA Moderna
$126.88 /

+17.7 (+16.21%)

NVAX Novavax
$125.68 /

+23.16 (+22.59%)

SAGE Sage Therapeutics
$75.59 /

-7.02 (-8.50%)

BIIB Biogen
$243.90 /

+1.85 (+0.76%)

RYTM Rhythm Pharmaceuticals
$29.27 /

+5.16 (+21.40%)

MARA Marathon Patent Group
$4.29 /

-0.805 (-15.80%)

RIOT Riot Blockchain
$6.25 /

-0.825 (-11.66%)

BIIB Biogen
$243.90 /

+1.85 (+0.76%)

AZN AstraZeneca
$52.59 /

-0.01 (-0.02%)

MRNA Moderna
$126.88 /

+17.7 (+16.21%)

NVAX Novavax
$125.68 /

+23.16 (+22.59%)

BIIB Biogen
$243.90 /

+1.85 (+0.76%)

MARA Marathon Patent Group
$4.29 /

-0.805 (-15.80%)

RIOT Riot Blockchain
$6.25 /

-0.825 (-11.66%)

Technical Analysis
NASDAQ market internals summary » 13:17
11/27/20
11/27
13:17
11/27/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 13:16
11/27/20
11/27
13:16
11/27/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 » 13:05
11/27/20
11/27
13:05
11/27/20
13:05
IWM

iShares Trust Russell 2000 Index Fund

$184.16 /

+0.61 (+0.33%)

, RUT

Russell 2000 Index

$0.00 /

+ (+0.00%)

For the holiday-shortened…

For the holiday-shortened week the Russell 2000 (RUT) broadly outperformed the megacap indexes by a wide margin. At time of writing the index was trading at 1852. For the coming week the upside objectives will be in the range of 1860-1900 or higher. Support will be in the range of 1840-1790. Best performing sectors were Energy, Technology, Basic Materials, and Industrials. The weakest were Health Care and Consumer Staples.

ShowHide Related Items >><<
IWM iShares Trust Russell 2000 Index Fund
$184.16 /

+0.61 (+0.33%)

IWM iShares Trust Russell 2000 Index Fund
$184.16 /

+0.61 (+0.33%)

IWM iShares Trust Russell 2000 Index Fund
$184.16 /

+0.61 (+0.33%)

RUT Russell 2000 Index
$0.00 /

+ (+0.00%)

Technical Analysis
On The Fly: Weekly technical notes for S&P 500 » 13:00
11/27/20
11/27
13:00
11/27/20
13:00
XLV

Health Care Select Sector SPDR

$109.31 /

+0.93 (+0.86%)

, XLP

Consumer Staples Sector SPDR

$66.84 /

-0.095 (-0.14%)

, XLI

Industrial Select Sector SPDR

$88.71 /

-0.29 (-0.33%)

, XLF

Financial Select Sector

$28.41 /

-0.145 (-0.51%)

, XLE

Energy Select Sector SPDR

$38.83 /

-0.52 (-1.32%)

, SPY

SPDR S&P 500 ETF Trust

$363.18 /

+0.54 (+0.15%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

The S&P 500 is set to…

The S&P 500 is set to end near highs of the week, trading at the top of the prior week range. With price last at 3636, the index is within striking distance of its life high. For the coming week the upside objectives will be in the range of 3640-3700. Support will be in the range of 3620-3550. For the holiday shortened week the best performing sectors were Energy (XLE), Financials (XLF), and Industrials (XLI). The worst performing sectors were Consumer Staples (XLP) and Health Care (XLV).

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$38.83 /

-0.52 (-1.32%)

SPY SPDR S&P 500 ETF Trust
$363.18 /

+0.54 (+0.15%)

SPX S&P 500
$0.00 /

+ (+0.00%)

XLV Health Care Select Sector SPDR
$109.31 /

+0.93 (+0.86%)

03/18/20
Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight
XLP Consumer Staples Sector SPDR
$66.84 /

-0.095 (-0.14%)

XLI Industrial Select Sector SPDR
$88.71 /

-0.29 (-0.33%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLF Financial Select Sector
$28.41 /

-0.145 (-0.51%)

XLE Energy Select Sector SPDR
$38.83 /

-0.52 (-1.32%)

07/06/20 Goldman Sachs
Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs
SPY SPDR S&P 500 ETF Trust
$363.18 /

+0.54 (+0.15%)

11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
SPX S&P 500
$0.00 /

+ (+0.00%)

11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
SPY SPDR S&P 500 ETF Trust
$363.18 /

+0.54 (+0.15%)

SPX S&P 500
$0.00 /

+ (+0.00%)

XLV Health Care Select Sector SPDR
$109.31 /

+0.93 (+0.86%)

XLP Consumer Staples Sector SPDR
$66.84 /

-0.095 (-0.14%)

XLI Industrial Select Sector SPDR
$88.71 /

-0.29 (-0.33%)

XLF Financial Select Sector
$28.41 /

-0.145 (-0.51%)

SPY SPDR S&P 500 ETF Trust
$363.18 /

+0.54 (+0.15%)

SPX S&P 500
$0.00 /

+ (+0.00%)

XLV Health Care Select Sector SPDR
$109.31 /

+0.93 (+0.86%)

XLP Consumer Staples Sector SPDR
$66.84 /

-0.095 (-0.14%)

XLI Industrial Select Sector SPDR
$88.71 /

-0.29 (-0.33%)

XLF Financial Select Sector
$28.41 /

-0.145 (-0.51%)

XLE Energy Select Sector SPDR
$38.83 /

-0.52 (-1.32%)

SPY SPDR S&P 500 ETF Trust
$363.18 /

+0.54 (+0.15%)

SPX S&P 500
$0.00 /

+ (+0.00%)

General news
Action Economics Survey results » 13:00
11/27/20
11/27
13:00
11/27/20
13:00

Action Economics Survey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Cronos Group call volume above normal and directionally bullish » 12:45
11/27/20
11/27
12:45
11/27/20
12:45
CRON

Cronos Group

$8.33 /

+0.375 (+4.71%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRON Cronos Group
$8.33 /

+0.375 (+4.71%)

CRON Cronos Group
$8.33 /

+0.375 (+4.71%)

11/16/20 Jefferies
Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
09/09/20 Stifel
Cronos CEO transition 'natural part' of company's evolution, says Stifel
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
06/24/20
Fly Intel: Top five analyst upgrades
CRON Cronos Group
$8.33 /

+0.375 (+4.71%)

CRON Cronos Group
$8.33 /

+0.375 (+4.71%)

CRON Cronos Group
$8.33 /

+0.375 (+4.71%)

CRON Cronos Group
$8.33 /

+0.375 (+4.71%)

General news
Treasury Action: gains have accelerated slightly ahead of the early close » 12:35
11/27/20
11/27
12:35
11/27/20
12:35

Treasury Action: gains…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Action: USD-JPY » 12:35
11/27/20
11/27
12:35
11/27/20
12:35

FX Action: USD-JPY was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Federal cannabis legalization to get House vote next week, Marijuana Moment says » 12:34
11/27/20
11/27
12:34
11/27/20
12:34
ACB

Aurora Cannabis

$8.90 /

+0.19 (+2.18%)

, CGC

Canopy Growth

$27.38 /

+0.53 (+1.97%)

, IGC

India Globalization Capital

$1.49 /

+0.025 (+1.71%)

, CANN

General Cannabis

$0.00 /

+ (+0.00%)

, ZYNE

Zynerba

$4.47 /

-0.13 (-2.83%)

, CRON

Cronos Group

$8.00 /

+0.045 (+0.57%)

, TLRY

Tilray

$7.75 /

+0.26 (+3.47%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, CNTTF

CannTrust Holdings

$0.00 /

+ (+0.00%)

, APHA

Aphria

$7.53 /

+0.505 (+7.19%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

A bill to federally…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$8.90 /

+0.19 (+2.18%)

CGC Canopy Growth
$27.38 /

+0.53 (+1.97%)

IGC India Globalization Capital
$1.49 /

+0.025 (+1.71%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$4.47 /

-0.13 (-2.83%)

CRON Cronos Group
$8.00 /

+0.045 (+0.57%)

TLRY Tilray
$7.75 /

+0.26 (+3.47%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CNTTF CannTrust Holdings
$0.00 /

+ (+0.00%)

APHA Aphria
$7.53 /

+0.505 (+7.19%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$8.90 /

+0.19 (+2.18%)

11/17/20 GLJ Research
With $0 target, GLJ says short Aurora Cannabis on recent rally
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Jefferies
Jefferies cuts Aurora Cannabis to Underperform after 'unjustified' re-rating
11/16/20 Jefferies
Aurora Cannabis downgraded to Underperform from Hold at Jefferies
CGC Canopy Growth
$27.38 /

+0.53 (+1.97%)

11/16/20 Jefferies
Canopy Growth price target raised to $21.10 from $16 at Jefferies
11/11/20 CIBC
Canopy Growth price target raised to C$32 from C$25 at CIBC
11/10/20 Canaccord
Canopy Growth price target raised to C$25 from C$22 at Canaccord
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
IGC India Globalization Capital
$1.49 /

+0.025 (+1.71%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
CANN General Cannabis
$0.00 /

+ (+0.00%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
ZYNE Zynerba
$4.47 /

-0.13 (-2.83%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
CRON Cronos Group
$8.00 /

+0.045 (+0.57%)

11/16/20 Jefferies
Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
09/09/20 Stifel
Cronos CEO transition 'natural part' of company's evolution, says Stifel
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
06/24/20
Fly Intel: Top five analyst upgrades
TLRY Tilray
$7.75 /

+0.26 (+3.47%)

11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Jefferies
Jefferies downgrades Tilray to Underperform as international markets stall
11/16/20 Jefferies
Tilray downgraded to Underperform from Hold at Jefferies
11/11/20
Fly Intel: Top five analyst downgrades
CVSI CV Sciences
$0.00 /

+ (+0.00%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
04/07/20 Cantor Fitzgerald
CV Sciences a takeover target after patent approval, says Cantor Fitzgerald
CNTTF CannTrust Holdings
$0.00 /

+ (+0.00%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
APHA Aphria
$7.53 /

+0.505 (+7.19%)

11/06/20 CIBC
Aphria price target raised to C$9 from C$8 at CIBC
10/16/20 CIBC
Aphria price target raised to C$8 from C$7.50 at CIBC
10/16/20 Cantor Fitzgerald
Aphria price target lowered to C$11.75 from C$15.50 at Cantor Fitzgerald
10/05/20 Cantor Fitzgerald
Aphria price target raised to C$15.50 from C$12.50 at Cantor Fitzgerald
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

11/18/20 Craig-Hallum
Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
11/17/20 Alliance Global Partners
Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global
09/28/20 Craig-Hallum
Trulieve Cannabis price target raised to $45 from $40 at Craig-Hallum
09/25/20 Alliance Global Partners
Trulieve Cannabis initiated with a Buy at Alliance Global Partners
ACB Aurora Cannabis
$8.90 /

+0.19 (+2.18%)

CGC Canopy Growth
$27.38 /

+0.53 (+1.97%)

IGC India Globalization Capital
$1.49 /

+0.025 (+1.71%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$4.47 /

-0.13 (-2.83%)

CRON Cronos Group
$8.00 /

+0.045 (+0.57%)

TLRY Tilray
$7.75 /

+0.26 (+3.47%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

APHA Aphria
$7.53 /

+0.505 (+7.19%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

  • 11
    Nov
ACB Aurora Cannabis
$8.90 /

+0.19 (+2.18%)

CGC Canopy Growth
$27.38 /

+0.53 (+1.97%)

IGC India Globalization Capital
$1.49 /

+0.025 (+1.71%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$4.47 /

-0.13 (-2.83%)

CRON Cronos Group
$8.00 /

+0.045 (+0.57%)

TLRY Tilray
$7.75 /

+0.26 (+3.47%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CNTTF CannTrust Holdings
$0.00 /

+ (+0.00%)

APHA Aphria
$7.53 /

+0.505 (+7.19%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$8.90 /

+0.19 (+2.18%)

CGC Canopy Growth
$27.38 /

+0.53 (+1.97%)

IGC India Globalization Capital
$1.49 /

+0.025 (+1.71%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$4.47 /

-0.13 (-2.83%)

CRON Cronos Group
$8.00 /

+0.045 (+0.57%)

TLRY Tilray
$7.75 /

+0.26 (+3.47%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

APHA Aphria
$7.53 /

+0.505 (+7.19%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$8.90 /

+0.19 (+2.18%)

CGC Canopy Growth
$27.38 /

+0.53 (+1.97%)

IGC India Globalization Capital
$1.49 /

+0.025 (+1.71%)

ZYNE Zynerba
$4.47 /

-0.13 (-2.83%)

CRON Cronos Group
$8.00 /

+0.045 (+0.57%)

TLRY Tilray
$7.75 /

+0.26 (+3.47%)

APHA Aphria
$7.53 /

+0.505 (+7.19%)

General news
FX Action: USD-CAD » 12:30
11/27/20
11/27
12:30
11/27/20
12:30

FX Action: USD-CAD hit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
UniCredit working with strategic advisers on updated plans, Reuters reports » 12:25
11/27/20
11/27
12:25
11/27/20
12:25
UNCRY

UniCredit

$0.00 /

+ (+0.00%)

UniCredit (UNCRY) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNCRY UniCredit
$0.00 /

+ (+0.00%)

06:25 Today Exane BNP Paribas
UniCredit downgraded to Neutral from Outperform at Exane BNP Paribas
11/10/20 AlphaValue
UniCredit upgraded to Buy from Reduce at AlphaValue
10/21/20 JPMorgan
UniCredit price target lowered to EUR 8 from EUR 9 at JPMorgan
08/11/20 UBS
UniCredit price target raised to EUR 8.80 from EUR 8.70 at UBS
UNCRY UniCredit
$0.00 /

+ (+0.00%)

Options
Canopy Growth call volume above normal and directionally bullish » 12:25
11/27/20
11/27
12:25
11/27/20
12:25
CGC

Canopy Growth

$27.19 /

+0.34 (+1.27%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$27.19 /

+0.34 (+1.27%)

CGC Canopy Growth
$27.19 /

+0.34 (+1.27%)

11/16/20 Jefferies
Canopy Growth price target raised to $21.10 from $16 at Jefferies
11/11/20 CIBC
Canopy Growth price target raised to C$32 from C$25 at CIBC
11/10/20 Canaccord
Canopy Growth price target raised to C$25 from C$22 at Canaccord
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
CGC Canopy Growth
$27.19 /

+0.34 (+1.27%)

CGC Canopy Growth
$27.19 /

+0.34 (+1.27%)

CGC Canopy Growth
$27.19 /

+0.34 (+1.27%)

CGC Canopy Growth
$27.19 /

+0.34 (+1.27%)

Technical Analysis
NASDAQ market internals summary » 12:17
11/27/20
11/27
12:17
11/27/20
12:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 12:16
11/27/20
11/27
12:16
11/27/20
12:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Teva receives tentative approval from FDA for micafungin sodium » 12:06
11/27/20
11/27
12:06
11/27/20
12:06
TEVA

Teva

$9.81 /

+0.06 (+0.62%)

The tentative approval…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$9.81 /

+0.06 (+0.62%)

TEVA Teva
$9.81 /

+0.06 (+0.62%)

06:53 Today H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
11/24/20 Oppenheimer
Teva initiated with a Perform at Oppenheimer
11/23/20 Citi
Citi recommends pair trade of overweight Endo, underweight Teva
10/13/20 Argus
Teva price target lowered to $11 from $14 at Argus
TEVA Teva
$9.81 /

+0.06 (+0.62%)

TEVA Teva
$9.81 /

+0.06 (+0.62%)

TEVA Teva
$9.81 /

+0.06 (+0.62%)

TEVA Teva
$9.81 /

+0.06 (+0.62%)

Options
Lithium Americas call volume above normal and directionally bullish » 12:05
11/27/20
11/27
12:05
11/27/20
12:05
LAC

Lithium Americas

$11.71 /

+0.65 (+5.88%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

10/21/20 Roth Capital
Lithium Americas downgraded to Neutral from Buy at Roth Capital
10/20/20 BMO Capital
Lithium Americas price target raised to C$10 from C$8 at BMO Capital
09/23/20 BMO Capital
BMO thinks Tesla project rights not related to Lithium Americas
06/25/20 BMO Capital
Lithium Americas price target raised to C$5 from C$4.40 at BMO Capital
LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

Periodicals
Volkswagen electric supermini at least three years away, FT reports » 11:59
11/27/20
11/27
11:59
11/27/20
11:59
VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Volkswagen will not…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

05:07 Today Exane BNP Paribas
Volkswagen downgraded to Neutral from Outperform at Exane BNP Paribas
10/22/20 Morgan Stanley
Volkswagen price target raised to EUR 148 from EUR 135 at Morgan Stanley
10/21/20 Societe Generale
Volkswagen price target raised to EUR 190 from EUR 184 at Societe Generale
10/19/20 Goldman Sachs
Volkswagen price target raised to EUR 179 from EUR 169 at Goldman Sachs
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

Options
BlackBerry call volume above normal and directionally bullish » 11:45
11/27/20
11/27
11:45
11/27/20
11:45
BB

BlackBerry

$6.17 /

+0.255 (+4.31%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BB BlackBerry
$6.17 /

+0.255 (+4.31%)

BB BlackBerry
$6.17 /

+0.255 (+4.31%)

06/25/20 Scotiabank
BlackBerry price target raised to $5 from $4.50 at Scotiabank
06/25/20 Canaccord
BlackBerry improvement anticipated throughout year, says Canaccord
04/01/20 MKM Partners
BlackBerry price target lowered to $4.50 from $7.00 at MKM Partners
04/01/20 TD Securities
BlackBerry downgraded to Hold from Buy at TD Securities
BB BlackBerry
$6.17 /

+0.255 (+4.31%)

BB BlackBerry
$6.17 /

+0.255 (+4.31%)

BB BlackBerry
$6.17 /

+0.255 (+4.31%)

BB BlackBerry
$6.17 /

+0.255 (+4.31%)

Recommendations
Rhythm's Imcivree label 'reads bullish' for possible basket trial, says Stifel » 11:25
11/27/20
11/27
11:25
11/27/20
11:25
RYTM

Rhythm Pharmaceuticals

$29.60 /

+5.49 (+22.77%)

Stifel analyst Derek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYTM Rhythm Pharmaceuticals
$29.60 /

+5.49 (+22.77%)

RYTM Rhythm Pharmaceuticals
$29.60 /

+5.49 (+22.77%)

10/26/20 Stifel
Rhythm Pharmaceuticals price target raised to $36 from $31 at Stifel
01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
RYTM Rhythm Pharmaceuticals
$29.60 /

+5.49 (+22.77%)

RYTM Rhythm Pharmaceuticals
$29.60 /

+5.49 (+22.77%)

Options
Aphria call volume above normal and directionally bullish » 11:25
11/27/20
11/27
11:25
11/27/20
11:25
APHA

Aphria

$7.56 /

+0.535 (+7.62%)

Bullish option flow…

Bullish option flow detected in Aphria with 40,980 calls trading, 4x expected, and implied vol increasing over 1 point to 80.45%. 11/27 weekly 7.5 calls and Jan-21 7.5 calls are the most active options, with total volume in those strikes near 7,900 contracts. The Put/Call Ratio is 0.06. Earnings are expected on January 14th.

ShowHide Related Items >><<
APHA Aphria
$7.56 /

+0.535 (+7.62%)

APHA Aphria
$7.56 /

+0.535 (+7.62%)

11/06/20 CIBC
Aphria price target raised to C$9 from C$8 at CIBC
10/16/20 CIBC
Aphria price target raised to C$8 from C$7.50 at CIBC
10/16/20 Cantor Fitzgerald
Aphria price target lowered to C$11.75 from C$15.50 at Cantor Fitzgerald
10/05/20 Cantor Fitzgerald
Aphria price target raised to C$15.50 from C$12.50 at Cantor Fitzgerald
APHA Aphria
$7.56 /

+0.535 (+7.62%)

APHA Aphria
$7.56 /

+0.535 (+7.62%)

APHA Aphria
$7.56 /

+0.535 (+7.62%)

APHA Aphria
$7.56 /

+0.535 (+7.62%)

Technical Analysis
NASDAQ market internals summary » 11:17
11/27/20
11/27
11:17
11/27/20
11:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 11:16
11/27/20
11/27
11:16
11/27/20
11:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Volume is above average for this time of day. Breadth is bullish across the board. Advancing Issues: 1519 / Declining Issues: 1511 -- for a ratio of 1 to 1. Advancing Volume: 726,619,000 / Declining Volume: 589,911,000 -- for a ratio of 1.2 to 1. New 52-Week Highs: 177 / New 52-Week Lows: 1.

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Options
FreightCar America call volume off the rails as shares jump 50% » 11:00
11/27/20
11/27
11:00
11/27/20
11:00
RAIL

FreightCar America

$2.85 /

+0.85 (+42.50%)

FreightCar America call…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAIL FreightCar America
$2.85 /

+0.85 (+42.50%)

RAIL FreightCar America
$2.85 /

+0.85 (+42.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.